CXCL1, which regulates reactive oxygen species release by neutrophils and stress kinase activation in a mouse model of NASH, can be altered by IL-22, attenuating NASH progression (121). Here, CXCL1 is linked to metabolic dysfunction-associated steatohepatitis.